Flavonoids as Potential Anti-Hepatocellular Carcinoma Agents: Recent Approaches Using HepG2 Cell Line

drug discoveries & therapeutics

Volumn 7, Issue 1, 2013, Pages 1-8

  Xia, Jufeng ^a   Gao, Jianjun ^a   Inagaki, Yoshinori ^a,b   Kokudo, Norihiro ^a   Nakata, Munehiro ^c   Tang, Wei ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKAI UNIVERSITY   (Japan)

Author keywords

Flavonoids; hepatocellular carcinoma; HepG2; herb medicine

Indexed keywords

EID: 85008737571     PISSN: 18817831     EISSN: 1881784x     Source Type: Journal    
DOI: 10.5582/ddt.2013.v7.1.1     Document Type: Article

References (75)

1. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006; 118:3030-3044.
2. Wong R, Sagar CM, Sagar SM. Integration of Chinese medicine into supportive cancer care: A modern role for an ancient tradition. Cancer Treat Rev. 2001; 27:235-246.
3. Gai RY, Xu HL, Qu XJ, Wang FS, Lou HX, Han JX, Nakata M, Kokudo N, Sugawara Y, Kuroiwa C, Tang W. Dynamic of modernizing traditional Chinese medicine and the standards system for its development. Drug Discov Ther. 2008; 2:2-4.
4. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. Flavonoids: A review of probable mechanisms of action and potential applications. Am J Clin Nutr. 2001; 74:418-425.
5. Ververidis F, Trantas E, Douglas C, Vollmer G, Kretzschmar G, Panopoulos N. Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part II: Reconstruction of multienzyme pathways in plants and microbes. Biotechnol J. 2007; 2:1235-1249.
6. Cui X, Wang Y, Kokudo N, Fang D, Tang W. Traditional Chinese medicine and related active compounds against hepatitis B virus infection. Biosci Trends. 2010; 4:39-47.
7. Handoussa H, Osmanova N, Ayoub N, Mahran L. Spicatic acid: A 4-carboxygentisic acid from Gentiana spicata extract with potential hepatoprotective activity. Drug Discov Ther. 2009; 3:278-286.
8. Abdel-Salam OME, Youness ER, Mohammed NA, Abd-Elmoniem M, Omara E, Sleem AA. Neuroprotective and hepatoprotective effects of micronized purified flavonoid fraction (Daflon®) in lipopolysaccharide-treated rats. Drug Discov Ther. 2012; 6:306-314.
9. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003; 3:768-780.
10. Dehn PF, White CM, Conners DE, Shipkey G, Cumbo TA. Characterization of the human hepatocellular carcinoma (hepg2) cell line as an in vitro model for cadmium toxicity studies. In Vitro Cell Dev Biol Anim. 2004; 40:172-182.
11. Roe AL, Snawder JE, Benson RW, Roberts DW, Casciano DA. HepG2 cells: An in vitro model for P450-dependent metabolism of acetaminophen. Biochem Biophys Res Commun. 1993; 190:15-19.
12. Van ISC, Maier O, Van Der Wouden JM, Hoekstra D. The subapical compartment and its role in intracellular trafficking and cell polarity. J Cell Physiol. 2000; 184:151-160.
13. van ISC, Hoekstra D. Polarized sphingolipid transport from the subapical compartment changes during cell polarity development. Mol Biol Cell. 2000; 11:1093-1101.
14. Liang RR, Zhang S, Qi JA, Wang ZD, Li J, Liu PJ, Huang C, Le XF, Yang J, Li ZF. Preferential inhibition of hepatocellular carcinoma by the flavonoid baicalein through blocking MEK-ERK signaling. Int J Oncol. 2012; 41:969-978.
15. Yang J, Yang Y, Tian L, Sheng XF, Liu F, Cao JG. Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells. World J Gastroenterol. 2011; 17:4298-4307.
16. Kim BR, Jeon YK, Nam MJ. A mechanism of apigenin-induced apoptosis is potentially related to antiangiogenesis and anti-migration in human hepatocellular carcinoma cells. Food Chem Toxicol. 2011; 49:1626-1632.
17. Jiang CP, Ding H, Shi DH, Wang YR, Li EG, Wu JH. Pro- apoptotic effects of tectorigenin on human hepatocellular carcinoma HepG2 cells. World J Gastroenterol. 2012; 18:1753-1764.
18. Zhang HT, Luo H, Wu J, Lan LB, Fan DH, Zhu KD, Chen XY, Wen M, Liu HM: Galangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway. World J Gastroenterol. 2010; 16:3377-3384.
19. Chang YF, Hsu YC, Hung HF, Lee HJ, Lui WY, Chi CW, Wang JJ. Quercetin induces oxidative stress and potentiates the apoptotic action of 2-methoxyestradiol in human hepatoma cells. Nutr Cancer. 2009; 61:735-745.
20. Kim I, Xu W, Reed JC. Cell death and endoplasmic reticulum stress: Disease relevance and therapeutic opportunities. Nat Rev Drug Discov. 2008; 7:1013-1030.
21. Li HB, Chen F. Isolation and purification of baicalein, wogonin and oroxylin A from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography. J Chromatogr A. 2005; 1074:107-110.
22. Mu R, Qi Q, Gu H, Wang J, Yang Y, Rong J, Liu W, Lu N, You Q, Guo Q. Involvement of p53 in oroxylin A-induced apoptosis in cancer cells. Mol Carcinog. 2009; 48:1159-1169.
23. Schmitz KJ, Wohlschlaeger J, Lang H, Sotiropoulos GC, Malago M, Steveling K, Reis H, Cicinnati VR, Schmid KW, Baba HA. Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol. 2008; 48:83-90.
24. Xu M, Lu N, Sun Z, Zhang H, Dai Q, Wei L, Li Z, You Q, Guo Q. Activation of the unfolded protein response contributed to the selective cytotoxicity of oroxylin A in human hepatocellular carcinoma HepG2 cells. Toxicol Lett. 2012; 212:113-125.
25. Hui KM, Huen MS, Wang HY, Zheng H, Sigel E, Baur R, Ren H, Li ZW, Wong JT, Xue H. Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi. Biochem Pharmacol. 2002; 64:1415-1424.
26. Xu M, Lu N, Zhang H, Dai Q, Wei L, Li Z, You Q, Guo Q. Wogonin induced cytotoxicity in human hepatocellular carcinoma cells by activation of unfolded protein response and inactivation of AKT. Hepatol Res. 2012. DOI: 10.1111/hepr.12036
27. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004; 305:626-629.
28. Yang JC, Cortopassi GA. Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c. Free Radic Biol Med. 1998; 24:624-631.
29. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 1999; 397: 441-446.
30. van Loo G, Schotte P, van Gurp M, Demol H, Hoorelbeke B, Gevaert K, Rodriguez I, Ruiz-Carrillo A, Vandekerckhove J, Declercq W, Beyaert R, Vandenabeele P. Endonuclease G: A mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. Cell Death Differ. 2001; 8:1136-1142.
31. Philchenkov A. Caspases: Potential targets for regulating cell death. J Cell Mol Med. 2004; 8:432-444.
32. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 1994; 371:346-347.
33. Fang R, Houghton PJ, Hylands PJ. Cytotoxic effects of compounds from Iris tectorum on human cancer cell lines. J Ethnopharmacol. 2008; 118:257-263.
34. Wang HC, Chung PJ, Wu CH, Lan KP, Yang MY, Wang CJ. Solanum nigrum L. polyphenolic extract inhibits hepatocarcinoma cell growth by inducing G2/M phase arrest and apoptosis. J Sci Food Agric. 2011; 91:178-185.
35. Jiang H, Ma Y, Chen X, Pan S, Sun B, Krissansen GW, Sun X. Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma. Cancer Sci. 2010; 101:975-983.
36. Sharma A, Upadhyay AK, Bhat MK. Inhibition of Hhsp27 and Hhsp40 potentiates 5-fluorouracil and carboplatin mediated cell killing in hepatoma cells. Cancer Biol Ther. 2009; 8:2104-2111.
37. Dhanasekaran DN, Reddy EP. JNK signaling in apoptosis. Oncogene. 2008; 27:6245-6251.
38. Yang XH, Zheng X, Cao JG, Xiang HL, Liu F, Lv Y. 8-Bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK. World J Gastroenterol. 2010; 16:3385-3393.
39. Fischer OM, Giordano S, Comoglio PM, Ullrich A. Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells. J Biol Chem. 2004; 279:28970-28978.
40. Shattuck DL, Miller JK, Carraway KL, 3rd, Sweeney C. Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells. Cancer Res. 2008; 68:1471-1477.
41. Jo MJ, Stolz DB, Esplen JE, Dorko K, Michalopoulos GK, Strom SC. Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J Biol Chem. 2000; 275:8806-8811.
42. Gentile A, Trusolino L, Comoglio PM. The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev. 2008; 27:85-94.
43. O'Brien LE, Tang K, Kats ES, Schutz-Geschwender A, Lipschutz JH, Mostov KE. ERK and MMPs sequentially regulate distinct stages of epithelial tubule development. Dev Cell. 2004; 7:21-32.
44. Marshall CJ. Specificity of receptor tyrosine kinase signaling-Transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995; 80:179-185.
45. Graziani A, Gramaglia D, Cantley LC, Comoglio PM. The tyrosine-phosphorylated hepatocyte growth-factor scatter factor receptor associates with phosphatidylinositol 3-kinase. J Biol Chem. 1991; 266:22087-22090.
46. Siegfried JM, Gubish CT, Rothstein ME, de Oliveira PEQ, Stabile LP. Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non-small-cell lung cancer. Mol Pharmacol. 2007; 72:769-779.
47. Jin J, Chang Y, Wei W, He YF, Hu SS, Wang D, Wu YJ. Prostanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro. Acta Pharmacol Sin. 2012; 33:701-709.
48. Shimizu M, Shirakami Y, Sakai H, Tatebe H, Nakagawa T, Hara Y, Weinstein IB, Moriwaki H. EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells. Cancer Lett. 2008; 262:10-18.
49. Gilmore TD. Introduction to NF-kB: Players, pathways, perspectives. Oncogene. 2006; 25:6680-6684.
50. Naugler WE, Karin M. NF-kappaB and cancer-identifyingtargets and mechanisms. Curr Opin Genet Dev. 2008, 18:19-26.
51. Bertazza L, Mocellin S. Tumor necrosis factor (TNF) biology and cell death. Front Biosci. 2008; 13:2736-2743.
52. Kubo F, Ueno S, Hiwatashi K, Sakoda M, Kawaida K, Nuruki K, Aikou T. Interleukin 8 in human hepatocellular carcinoma correlates with cancer cell invasion of vessels but not with tumor angiogenesis. Ann Surg Oncol. 2005; 12:800-807.
53. Dorn C, Weiss TS, Heilmann J, Hellerbrand C. Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells. Int J Oncol. 2010; 36:435-441.
54. Garcia-Mediavilla V, Crespo I, Collado PS, Esteller A, Sanchez-Campos S, Tunon MJ, Gonzalez-Gallego J. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kB pathway in Chang Liver cells. Eur J Pharmacol. 2007; 557:221-229.
55. Granado-Serrano AB, Martin MA, Bravo L, Goya L, Ramos S. Quercetin attenuates TNF-induced inflammation in hepatic cells by inhibiting the NF-kB pathway. Nutr Cancer. 2012; 64:588-598.
56. Chen FH, Lu N, Zhang HW, Zhao L, He LC, Sun HP, You QD, Li ZY, Guo QL. LYG-202 augments tumor necrosis factor-α-induced apoptosis via attenuating casein kinase 2-depend ent nuclear factor-KB pathway in HepG2 cells. Mol Pharmacol. 2012, 82: 958-971.
57. Hwang JT, Park OJ, Lee YK, Sung MJ, Hur HJ, Kim MS, Ha JH, Kwon DY. Antitumor effect of luteolin is accompanied by AMP-activated protein kinase and nuclear factor-KB modulation in HepG2 hepatocarcinoma cells. Int J Mol Med. 2011, 28:25-31.
58. Granado-Serrano AB, Martin MA, Haegeman G, Goya L, Bravo L, Ramos S. Epicatechin induces NF-kappaB, activator protein-1 (AP-1) and nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) via phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) and extracellular regulated kinase (ERK) signalling in HepG2 cells. Br J Nutr. 2010; 103:168-179.
59. Yeh MH, Kao ST, Hung CM, Liu CJ, Lee KH, Yeh CC. Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells. Toxicol Lett. 2009; 184:204-210.
60. De Maio A. Heat shock proteins: Facts, thoughts, and dreams. Shock. 1999; 11:1-12.
61. Borges JC, Ramos CHI. Protein folding assisted by chaperones. Protein Pept Lett. 2005; 12:257-261.
62. Charette SJ, Lavoie JN, Lambert H, Landry J. Inhibition of Daxx-mediated apoptosis by heat shock protein 27. Mol Cell Biol. 2000; 20:7602-7612.
63. Rane MJ, Pan Y, Singh S, Powell DW, Wu R, Cummins T, Chen Q, McLeish KR, Klein JB. Heat shock protein 27 controls apoptosis by regulating Akt activation. J Biol Chem. 2003; 278:27828-27835.
64. Demidenko ZN, Vivo C, Halicka HD, Li CJ, Bhalla K, Broude EV, Blagosklonny MV. Pharmacological induction of Hsp70 protects apoptosis-prone cells from doxorubicin: comparison with caspase-inhibitor-and cycle-arrest-mediated cytoprotection. Cell Death Differ. 2006; 13:1434-1441.
65. Zhou J, Fang L, Yao WX, Zhao X, Wei Y, Zhou H, Xie H, Wang LY, Chen LJ. Effect of quercetin on heat shock protein expression in HepG2 cells determined by SILAC. Zhonghua Zhong Liu Za Zhi. 2011; 33:737-741.
66. Sherr CJ. Principles of tumor suppression. Cell. 2004; 116:235-246.
67. Chen CH, Huang TS, Wong CH, Hong CL, Tsai YH, Liang CC, Lu FJ, Chang WH. Synergistic anticancer effect of baicalein and silymarin on human hepatoma HepG2 Cells. Food Chem Toxicol. 2009; 47:638-644.
68. Androutsopoulos VP, Spandidos DA. The flavonoids diosmetin and luteolin exert synergistic cytostatic effects in human hepatoma HepG2 cells via CYP1A-catalyzed metabolism, activation of JNK and ERK and P53/P21 upregulation. J Nutr Biochem. 2013; 24:496-504.
69. Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ. Viral hepatocarcinogenesis: from infection to cancer. Liver Int. 2008; 28:175-188.
70. He W, Li LX, Liao QJ, Liu CL, Chen XL. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication-inducible cell line. World J Gastroenterol. 2011; 17:1507-1514.
71. Chou SC, Huang TJ, Lin EH, Huang CH, Chou CH. Antihepatitis B virus constituents of Solanum erianthum. Nat Prod Commun. 2012; 7:153-156.
72. Guo Q, Zhao L, You Q, Yang Y, Gu H, Song G, Lu N, Xin J. Antihepatitis B virus activity of wogonin in vitro and in vivo. Antiviral Res. 2007; 74:16-24.
73. Lee JC, Tseng CK, Wu SF, Chang FR, Chiu CC, Wu YC. San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression. J Viral Hepat. 2011; 18:e315-324.
74. Haid S, Novodomska A, Gentzsch J, et al. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes. Gastroenterology. 2012; 143:213-222.
75. Mesaik MA; Azizuddin, Murad S, Khan KM, Tareen RB, Ahmed A; Atta-ur-Rahman, Choudhary MI. Isolation and immunomodulatory properties of a flavonoid, casticin from Vitex agnus-castus. Phytother Res. 2009; 23:1516-1520.